AVTX vs CVX · P/E 0.0, $51.5M cap vs P/E 17, rev $118.66B
Avalo Therapeutics Inc (AVTX) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the AVTX and CVX stock pages for the full models.
Not investment advice.